Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-004851-30Phase 3Terminated
Phase 3, randomised, double-blind trial in chronic neuropathic pain and chronic pain comparing Gabapentin liquid formulation with Tramadol (2 arms). Primary endpoint: Percentage of responders to treatments. Started May 2016; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-004851-30.